{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:38:42Z","timestamp":1788824322282,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The peak incidence of inflammatory bowel disease (IBD) coincides with a woman\u2019s prime reproductive years. The management of IBD during pregnancy can be challenging for healthcare professionals, underpinning the need for a multi-disciplinary approach with shared decision-making with the patient. Pre-conception counselling can address patient concerns, improve pregnancy specific IBD patient knowledge and provide a personalized risk assessment, to ensure optimal maternal and fetal outcomes. Most women with IBD have fertility rates comparable with the general population, although voluntary childlessness is common among women with IBD. IBD disease activity at conception and during pregnancy is a key determinant of the course of IBD during pregnancy. Active IBD during pregnancy is associated with adverse pregnancy-related outcomes, including spontaneous abortion, small for gestational age baby and preterm birth, emphasizing the importance of ensuring disease remission prior to conception. Most IBD medications (5-aminosalicylates, thiopurines if already initiated pre-conception, corticosteroids and biologic medications) are considered safe and low risk during pregnancy and breastfeeding, except for methotrexate, JAK-inhibitors, ozanimod and allopurinol and maintaining remission throughout gestation should be the priority. Most women with IBD can have a vaginal delivery, but cesarean section should be considered in active perianal disease and history of ileal pouch surgery. This narrative review outlines the current evidence for the\u00a0management of IBD in pregnancy, as well as considering the pre-conceptual and post-partum period.<\/jats:p>","DOI":"10.1007\/s12664-024-01563-9","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T02:01:40Z","timestamp":1715738500000},"page":"152-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Conception, pregnancy and inflammatory bowel disease\u2014Current concepts for the practising clinician"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-9245","authenticated-orcid":false,"given":"Eleanor","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Chatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-6251","authenticated-orcid":false,"given":"Jimmy K.","family":"Limdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"1563_CR1","doi-asserted-by":"publisher","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.e42; quiz e30. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.001.","DOI":"10.1053\/j.gastro.2011.10.001."},{"key":"1563_CR2","doi-asserted-by":"publisher","unstructured":"Selinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7:e206-13. https:\/\/doi.org\/10.1016\/j.crohns.2012.09.010.","DOI":"10.1016\/j.crohns.2012.09.010."},{"key":"1563_CR3","doi-asserted-by":"publisher","unstructured":"Liu E, Laube R, Leong RW, Fraser A, Selinger C, Limdi JK.\u00a0\u00a0Managing inflammatory bowel disease in pregnancy: health care professionals\u2019 involvement, knowledge, and decision making. Inflamm Bowel Dis. 2023;29:522\u201330. https:\/\/doi.org\/10.1093\/ibd\/izac101.","DOI":"10.1093\/ibd\/izac101"},{"key":"1563_CR4","doi-asserted-by":"publisher","unstructured":"Limdi JK, Farraye J, Cannon R, Woodhams E, Farraye FA.\u00a0Contraception, venous thromboembolism, and inflammatory bowel disease: what clinicians (and patients) should know. Inflamm Bowel Dis. 2019;25:1603\u201312. https:\/\/doi.org\/10.1093\/ibd\/izz025.","DOI":"10.1093\/ibd\/izz025"},{"key":"1563_CR5","doi-asserted-by":"publisher","unstructured":"Gawron LM, Gawron AJ, Kasper A, Hammond C, Keefer L.\u00a0Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey. Contraception. 2014;89:419\u201325. https:\/\/doi.org\/10.1016\/j.contraception.2013.","DOI":"10.1016\/j.contraception.2013"},{"key":"1563_CR6","doi-asserted-by":"publisher","unstructured":"Winter RW, Boyd T, Chan WW, Levy AN, Friedman S.\u00a0\u00a0Risk factors for voluntary childlessness in men and women with inflammatory bowel disease. Inflamm Bowel Dis. 2022;28:1927\u201331. https:\/\/doi.org\/10.1093\/ibd\/izac104.","DOI":"10.1093\/ibd\/izac104"},{"key":"1563_CR7","doi-asserted-by":"publisher","unstructured":"Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:847\u201353. https:\/\/doi.org\/10.1111\/apt.12478.","DOI":"10.1111\/apt.12478"},{"key":"1563_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","volume":"17","author":"J Torres","year":"2023","unstructured":"Torres J, Chaparro M, Julsgaard M, et al. European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohns Colitis. 2023;17:1\u201327. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac115.","journal-title":"J Crohns Colitis."},{"key":"1563_CR9","doi-asserted-by":"publisher","unstructured":"Ban L, Tata LJ, Humes DJ, Fiaschi L, Card T.\u00a0Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Aliment Pharmacol Ther. 2015;42:855\u201366. https:\/\/doi.org\/10.1111\/apt.13354.","DOI":"10.1111\/apt.13354"},{"key":"1563_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ibd.20082","volume":"13","author":"SR Marri","year":"2007","unstructured":"Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:591\u20139. https:\/\/doi.org\/10.1002\/ibd.20082.","journal-title":"Inflamm Bowel Dis."},{"key":"1563_CR11","doi-asserted-by":"publisher","unstructured":"\u015eenate\u015f E, \u00c7olak Y, Erdem ED, et al. Serum anti-M\u00fcllerian hormone levels are lower in reproductive-age women with Crohn\u2019s disease compared to healthy control women. J Crohns Colitis. 2013;7:e29\u201334. https:\/\/doi.org\/10.1016\/j.crohns.2012.03.003.","DOI":"10.1016\/j.crohns.2012.03.003"},{"key":"1563_CR12","doi-asserted-by":"publisher","unstructured":"Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS.\u00a0\u00a0Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis. 2011;26:1365\u201374. https:\/\/doi.org\/10.1007\/s00384-011-1274-9.","DOI":"10.1007\/s00384-011-1274-9"},{"key":"1563_CR13","doi-asserted-by":"publisher","unstructured":"Lee S, Crowe M, Seow CH, et al. Surgery for inflammatory bowel disease has unclear impact on female fertility: a Cochrane collaboration systematic review. J Can Assoc Gastroenterol. 2020;4:115\u201324. https:\/\/doi.org\/10.1093\/jcag\/gwaa010.","DOI":"10.1093\/jcag\/gwaa010"},{"key":"1563_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019;156:1508\u201324. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.022.","journal-title":"Gastroenterology."},{"key":"1563_CR15","doi-asserted-by":"publisher","unstructured":"Laube R, Liu E, Li Y, Leong RW, Limdi J, Selinger C.\u00a0Gastroenterology team members\u2019 knowledge and practices with fertility therapy for women with inflammatory bowel disease. Therap Adv Gastroenterol. 2022;15:175628482210875. https:\/\/doi.org\/10.1177\/17562848221087543.","DOI":"10.1177\/17562848221087543"},{"key":"1563_CR16","doi-asserted-by":"publisher","unstructured":"Laube R, Tran Y, Paramsothy S, Leong RW.\u00a0Assisted reproductive technology in Crohn\u2019s disease and ulcerative colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2021;116:2334\u201344. https:\/\/doi.org\/10.14309\/ajg.0000000000001537.","DOI":"10.14309\/ajg.0000000000001537"},{"key":"1563_CR17","doi-asserted-by":"publisher","unstructured":"Selinger CP, Nelson-Piercy C, Fraser A, et al. IBD in pregnancy: recent advances, practical management. Frontline Gastroenterol. 2021;12:214\u201324. https:\/\/doi.org\/10.1136\/flgastro-2019-101371.","DOI":"10.1136\/flgastro-2019-101371"},{"key":"1563_CR18","doi-asserted-by":"publisher","unstructured":"Moller FT, Andersen V, Wohlfahrt J, Jess T.\u00a0Familial risk of inflammatory bowel disease: a population-based cohort study 1977\u20132011. Am J Gastroenterol. 2015;110:564\u201371. https:\/\/doi.org\/10.1038\/ajg.2015.50.","DOI":"10.1038\/ajg.2015.50"},{"key":"1563_CR19","doi-asserted-by":"publisher","unstructured":"Nguyen GC, Seow CH, Maxwell C, et al. The toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150:734\u201357.e1. https:\/\/doi.org\/10.1053\/j.gastro.2015.12.003.","DOI":"10.1053\/j.gastro.2015.12.003"},{"key":"1563_CR20","doi-asserted-by":"publisher","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68 Suppl 3:s1\u2013106. https:\/\/doi.org\/10.1136\/gutjnl-2019-318484.","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"1563_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/flgastro-2020-101459","volume":"12","author":"C Selinger","year":"2021","unstructured":"Selinger C, Carey N, Cassere S, et al. Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society. Frontline Gastroenterol. 2021;12:182\u20137. https:\/\/doi.org\/10.1136\/flgastro-2020-101459.","journal-title":"Frontline Gastroenterol."},{"key":"1563_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/flgastro-2020-101546","volume":"12","author":"S Wolloff","year":"2021","unstructured":"Wolloff S, Moore E, Glanville T, et al. Provision of care for pregnant women with IBD in the UK: the current landscape. Frontline Gastroenterol. 2021;12:487\u201392. https:\/\/doi.org\/10.1136\/flgastro-2020-101546.","journal-title":"Frontline Gastroenterol."},{"key":"1563_CR23","doi-asserted-by":"publisher","unstructured":"de Lima A, Zelinkova Z, Mulders AG, van der Woude CJ.\u00a0Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol. 2016;14:1285-92.e1. https:\/\/doi.org\/10.1016\/j.cgh.2016.03.018.","DOI":"10.1016\/j.cgh.2016.03.018"},{"key":"1563_CR24","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226:S1108-19. https:\/\/doi.org\/10.1016\/j.ajog.2020.08.045.","journal-title":"Am J Obstet Gynecol."},{"key":"1563_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00404-020-05557-8","volume":"301","author":"A Rottenstreich","year":"2020","unstructured":"Rottenstreich A, Fridman Lev S, et al. Disease flare at prior pregnancy and disease activity at conception are important determinants of disease relapse at subsequent pregnancy in women with inflammatory bowel diseases. Arch Gynecol Obstet. 2020;301:1449\u201354. https:\/\/doi.org\/10.1007\/s00404-020-05557-8.","journal-title":"Arch Gynecol Obstet."},{"key":"1563_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/apt.12412","volume":"38","author":"N Pedersen","year":"2013","unstructured":"Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38:501\u201312. https:\/\/doi.org\/10.1111\/apt.12412.","journal-title":"Aliment Pharmacol Ther."},{"key":"1563_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ecco-jcc\/jjaa225","volume":"15","author":"MA Kim","year":"2021","unstructured":"Kim MA, Kim YH, Chun J, et al. The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2021;15:719\u201332. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa225.","journal-title":"J Crohns Colitis."},{"key":"1563_CR28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2006.00602.x","volume":"101","author":"L Riis","year":"2006","unstructured":"Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a european cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101:1539\u201345. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00602.x.","journal-title":"Am J Gastroenterol."},{"key":"1563_CR29","doi-asserted-by":"publisher","unstructured":"Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA.\u00a0Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007;133:1106\u201312. https:\/\/doi.org\/10.1053\/j.gastro.2007.07.019.","DOI":"10.1053\/j.gastro.2007.07.019"},{"key":"1563_CR30","doi-asserted-by":"publisher","unstructured":"Fonager K, S\u00f8rensen HT, Olsen J, Dahlerup JF, Rasmussen SN.\u00a0\u00a0Pregnancy outcome for women with Crohn\u2019s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426\u201330. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.00698.x.","DOI":"10.1111\/j.1572-0241.1998.00698.x"},{"key":"1563_CR31","doi-asserted-by":"publisher","unstructured":"Rottenstreich A, Shifman Z, Grisaru-Granovksy S, Mishael T, Koslowsky B, Bar-Gil Shitrit A.\u00a0Factors associated with inflammatory bowel disease flare during pregnancy among women with preconception remission. Dig Dis Sci. 2021;66:1189\u201394. https:\/\/doi.org\/10.1007\/s10620-020-06282-7.","DOI":"10.1007\/s10620-020-06282-7"},{"key":"1563_CR32","doi-asserted-by":"publisher","unstructured":"Rahimi R, Nikfar S, Rezaie A, Abdollahi M.\u00a0Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 2008;25:271\u20135. https:\/\/doi.org\/10.1016\/j.reprotox.2007.11.010.","DOI":"10.1016\/j.reprotox.2007.11.010"},{"key":"1563_CR33","doi-asserted-by":"publisher","unstructured":"Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.\u00a0Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:15\u201322. https:\/\/doi.org\/10.1002\/ibd.22948.","DOI":"10.1002\/ibd.22948"},{"key":"1563_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","volume":"160","author":"U Mahadevan","year":"2021","unstructured":"Mahadevan U, Long MD, Kane SV, et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021;160:1131\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.038.","journal-title":"Gastroenterology."},{"key":"1563_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/ecco-jcc\/jjv189","volume":"10","author":"SA van den Berg","year":"2016","unstructured":"van den Berg SA, de Boer M, van der Meulen-de Jong AE, et al. Safety of tioguanine during pregnancy in inflammatory bowel disease. J Crohns Colitis. 2016;10:159\u201365. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv189.","journal-title":"J Crohns Colitis."},{"key":"1563_CR36","doi-asserted-by":"publisher","unstructured":"Simsek M, Opperman RCM, Mulder CJJ, Lambalk CB, de Boer NKH.\u00a0\u00a0The teratogenicity of allopurinol: a comprehensive review of animal and human studies. Reprod Toxicol. 2018;81:180\u20137. https:\/\/doi.org\/10.1016\/j.reprotox.2018.08.012.","DOI":"10.1016\/j.reprotox.2018.08.012"},{"key":"1563_CR37","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1128\/AAC.06477-11","volume":"56","author":"CA Koss","year":"2012","unstructured":"Koss CA, Baras DC, Lane SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother. 2012;56:4800\u20135. https:\/\/doi.org\/10.1128\/AAC.06477-11.","journal-title":"Antimicrob Agents Chemother."},{"key":"1563_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ecco-jcc\/jjv006","volume":"9","author":"YPY Leung","year":"2015","unstructured":"Leung YPY, Kaplan GG, Coward S, et al. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease. J Crohns Colitis. 2015;9:223\u201330. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv006.","journal-title":"J Crohns Colitis."},{"key":"1563_CR39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1503\/cmaj.101063","volume":"183","author":"A Hviid","year":"2011","unstructured":"Hviid A, Molgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. Can Med Assoc J. 2011;183:796\u2013804. https:\/\/doi.org\/10.1503\/cmaj.101063.","journal-title":"Can Med Assoc J."},{"key":"1563_CR40","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1136\/gutjnl-2021-325317","volume":"71","author":"FD Odufalu","year":"2022","unstructured":"Odufalu FD, Long M, Lin K, et al. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Gut. 2022;71:1766\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2021-325317.","journal-title":"Gut."},{"key":"1563_CR41","doi-asserted-by":"publisher","unstructured":"Luu M, Benzenine E, Doret M, et al. Continuous anti-TNF\u03b1 use throughout pregnancy: possible complications for the mother but not for the fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). Am J Gastroenterol. 2018;113:1669\u201377. https:\/\/doi.org\/10.1038\/s41395-018-0176-7.","DOI":"10.1038\/s41395-018-0176-7"},{"key":"1563_CR42","doi-asserted-by":"publisher","unstructured":"Nielsen OH, Gubatan JM, Juhl CB, Streett SE, Maxwell C.\u00a0\u00a0Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:74-87.e3. https:\/\/doi.org\/10.1016\/j.cgh.2020.09.021.","DOI":"10.1016\/j.cgh.2020.09.021"},{"key":"1563_CR43","doi-asserted-by":"publisher","unstructured":"Mahadevan U, Vermeire S, Lasch K, et al. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45:941\u201350. https:\/\/doi.org\/10.1111\/apt.13960.","DOI":"10.1111\/apt.13960"},{"key":"1563_CR44","doi-asserted-by":"publisher","unstructured":"Scherl E, Jacobstein D, Murphy C, et al. A109 Pregnancy outcomes in women exposed to ustekinumab in the Crohn\u2019s disease clinical development program. J Can Assoc Gastroenterol. 2018;1 Suppl_2:166. https:\/\/doi.org\/10.1093\/jcag\/gwy009.109.","DOI":"10.1093\/jcag\/gwy009.109"},{"key":"1563_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/apt.16192","volume":"53","author":"P Wils","year":"2021","unstructured":"Wils P, Seksik P, Stefanescu C, et al. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Aliment Pharmacol Ther. 2021;53:460\u201370. https:\/\/doi.org\/10.1111\/apt.16192.","journal-title":"Aliment Pharmacol Ther."},{"key":"1563_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/apt.15539","volume":"51","author":"A Moens","year":"2020","unstructured":"Moens A, van der Woude CJ, Julsgaard M, et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment Pharmacol Ther. 2020;51:129\u201338. https:\/\/doi.org\/10.1111\/apt.15539.","journal-title":"Aliment Pharmacol Ther."},{"key":"1563_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/17562848211018097","volume":"9","author":"M Chaparro","year":"2021","unstructured":"Chaparro M, Garc\u00edaDonday M, Calvi\u00f1o Suarez C, et al. P0415 Safety of inflammatory bowel disease drugs during pregnancy and breastfeeding: mothers and babies\u2019 outcomes (dumbo registry). United European Gastroenterol J. 2021;9:509\u201310. https:\/\/doi.org\/10.1177\/17562848211018097.","journal-title":"United European Gastroenterol J."},{"key":"1563_CR48","doi-asserted-by":"publisher","unstructured":"Liu E, Aslam N, Nigam G, Limdi JK.\u00a0Tofacitinib and newer JAK inhibitors in inflammatory bowel disease\u2014where we are and where we are going. Drugs Context. 2022;8:1\u201317. https:\/\/doi.org\/10.7573\/dic.2021-11-4.","DOI":"10.7573\/dic.2021-11-4"},{"key":"1563_CR49","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1093\/ibd\/izy160","volume":"24","author":"U Mahadevan","year":"2018","unstructured":"Mahadevan U, Dubinsky MC, Su C, et al. Outcomes of pregnancies with maternal\/paternal exposure in the tofacitinib safety databases for ulcerative colitis. Inflamm Bowel Dis. 2018;24:2494\u2013500. https:\/\/doi.org\/10.1093\/ibd\/izy160.","journal-title":"Inflamm Bowel Dis."},{"key":"1563_CR50","unstructured":"EMA. EMA Jyseleca Summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/jyseleca-epar-product-information_en.pdf. Accessed 17 December\u00a02023."},{"key":"1563_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1242\/dev.094805","volume":"141","author":"K Mendelson","year":"2014","unstructured":"Mendelson K, Evans T, Hla T. Sphingosine 1-phosphate signalling. Development. 2014;141:5\u20139. https:\/\/doi.org\/10.1242\/dev.094805.","journal-title":"Development."},{"key":"1563_CR52","doi-asserted-by":"publisher","unstructured":"Dubinsky MC, Mahadevan U, Charles L, et al. DOP53 Pregnancy outcomes in the ozanimod clinical development program in relapsing multiple sclerosis, ulcerative colitis, and Crohn\u2019s disease. J Crohns Colitis. 2021;15 Supplement_1:S088-9. https:\/\/doi.org\/10.1093\/ibd\/izae011.","DOI":"10.1093\/ibd\/izae011"},{"key":"1563_CR53","doi-asserted-by":"publisher","unstructured":"Tandon P, Leung K, Yusuf A, Huang VW.\u00a0\u00a0Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy. J Clin Gastroenterol. 2019;53:574\u201381. https:\/\/doi.org\/10.1097\/MCG.0000000000001244.","DOI":"10.1097\/MCG.0000000000001244"},{"key":"1563_CR54","doi-asserted-by":"publisher","unstructured":"ASGE Standard of Practice Committee; Shergill AK, Ben-Menachem T,\u00a0et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc. 2012;76:18\u201324. https:\/\/doi.org\/10.1016\/j.gie.2012.02.029.","DOI":"10.1016\/j.gie.2012.02.029"},{"key":"1563_CR55","doi-asserted-by":"publisher","unstructured":"Ko MS, Rudrapatna VA, Avila P, Mahadevan U.\u00a0\u00a0Safety of flexible sigmoidoscopy in pregnant patients with known or suspected inflammatory bowel disease. Dig Dis Sci. 2020;65:2979\u201385. https:\/\/doi.org\/10.1007\/s10620-020-06122-8.","DOI":"10.1007\/s10620-020-06122-8"},{"key":"1563_CR56","doi-asserted-by":"publisher","unstructured":"De Voogd F, Joshi H, Van Wassenaer E, Bots S, D'Haens G, Gecse K.\u00a0Intestinal ultrasound to evaluate treatment response during pregnancy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2022;28:1045\u201352. https:\/\/doi.org\/10.1093\/ibd\/izab216.","DOI":"10.1093\/ibd\/izab216"},{"key":"1563_CR57","doi-asserted-by":"publisher","unstructured":"Stern MD, Kopylov U, Ben-Horin S, Apter S, Amitai MM.\u00a0Magnetic resonance enterography in pregnant women with Crohn\u2019s disease: case series and literature review. BMC Gastroenterol. 2014;14:146. https:\/\/doi.org\/10.1186\/1471-230X-14-146.","DOI":"10.1186\/1471-230X-14-146"},{"key":"1563_CR58","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/ecco-jcc\/jjac050","volume":"16","author":"M Chaparro","year":"2022","unstructured":"Chaparro M, Kunovsk\u00fd L, Aguas M, et al. Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes from an ECCO CONFER multicentre case series (scar study). J Crohns Colitis. 2022;16:1428\u201335. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac050.","journal-title":"J Crohns Colitis."},{"key":"1563_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/codi.13413","volume":"19","author":"S Killeen","year":"2017","unstructured":"Killeen S, Gunn J, Hartley J. Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy. Colorectal Dis. 2017;19:123\u201338. https:\/\/doi.org\/10.1111\/codi.13413.","journal-title":"Colorectal Dis."},{"key":"1563_CR60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/uog.20272","volume":"53","author":"LJ Salomon","year":"2019","unstructured":"Salomon LJ, Alfirevic Z, da Silva CF, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol. 2019;53:715\u201323. https:\/\/doi.org\/10.1002\/uog.20272.","journal-title":"Ultrasound Obstet Gynecol."},{"key":"1563_CR61","doi-asserted-by":"publisher","unstructured":"Kim YH, Pfaller B, Marson A, Yim HW, Huang V, Ito S.\u00a0The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period.\u00a0Medicine (Baltimore).\u00a0\u00a02019;98:e17309. https:\/\/doi.org\/10.1097\/MD.0000000000017309.","DOI":"10.1097\/MD.0000000000017309"},{"key":"1563_CR62","doi-asserted-by":"publisher","unstructured":"ACOG Committee Opinion No. 761: Cesarean delivery on maternal request. Obstet Gynecol. 2019;133:E73\u20137. https:\/\/doi.org\/10.1097\/AOG.0000000000003006.","DOI":"10.1097\/AOG.0000000000003006"},{"key":"1563_CR63","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/MIB.0000000000001112","volume":"23","author":"A Foulon","year":"2017","unstructured":"Foulon A, Dupas JL, Sabbagh C, et al. Defining the most appropriate delivery mode in women with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:712\u201320. https:\/\/doi.org\/10.1097\/MIB.0000000000001112.","journal-title":"Inflamm Bowel Dis."},{"key":"1563_CR64","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/DCR.0b013e3182a41381","volume":"57","author":"Q Hatch","year":"2014","unstructured":"Hatch Q, Champagne BJ, Maykel JA, et al. Crohn\u2019s disease and pregnancy. Dis Colon Rectum. 2014;57:174\u20138. https:\/\/doi.org\/10.1097\/DCR.0b013e3182a41381.","journal-title":"Dis Colon Rectum."},{"key":"1563_CR65","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10350-007-0240-7","volume":"50","author":"JA Cornish","year":"2007","unstructured":"Cornish JA, Tan E, Teare J, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum. 2007;50:1128\u201338. https:\/\/doi.org\/10.1007\/s10350-007-0240-7.","journal-title":"Dis Colon Rectum."},{"key":"1563_CR66","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10350-004-0569-0","volume":"47","author":"D Hahnloser","year":"2004","unstructured":"Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47:1127\u201335. https:\/\/doi.org\/10.1007\/s10350-004-0569-0.","journal-title":"Dis Colon Rectum."},{"key":"1563_CR67","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10350-005-0124-7","volume":"48","author":"FH Remzi","year":"2005","unstructured":"Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum. 2005;48:1691\u20139. https:\/\/doi.org\/10.1007\/s10350-005-0124-7.","journal-title":"Dis Colon Rectum."},{"key":"1563_CR68","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/codi.16098","volume":"24","author":"PAPooSE Study Group","year":"2022","unstructured":"PAPooSE Study Group. Pregnancy outcomes after stoma surgery for inflammatory bowel disease: the results of a retrospective multicentre audit. Colorectal Dis. 2022;24:838\u201344. https:\/\/doi.org\/10.1111\/codi.16098.","journal-title":"Colorectal Dis."},{"key":"1563_CR69","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izz313","volume":"26","author":"A Yu","year":"2020","unstructured":"Yu A, Friedman S, Ananthakrishnan AN. Incidence and predictors of flares in the postpartum year among women with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1926\u201332. https:\/\/doi.org\/10.1093\/ibd\/izz313.","journal-title":"Inflamm Bowel Dis."},{"key":"1563_CR70","doi-asserted-by":"publisher","unstructured":"Malhi G, Tandon P, Perlmutter JW, Nguyen G, Huang V.\u00a0Risk factors for postpartum disease activity in women with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2022;28:1090\u20139. https:\/\/doi.org\/10.1093\/ibd\/izab206.","DOI":"10.1093\/ibd\/izab206"},{"key":"1563_CR71","doi-asserted-by":"publisher","unstructured":"Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN.\u00a0\u00a0Systematic review with meta-analysis: breastfeeding and the risk of Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46:780\u20139. https:\/\/doi.org\/10.1111\/apt.14291.","DOI":"10.1111\/apt.14291"},{"key":"1563_CR72","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2016.10.013","volume":"152","author":"U Mahadevan","year":"2017","unstructured":"Mahadevan U, McConnell RA, Chambers CD. Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel disease. Gastroenterology. 2017;152:451-62.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.013.","journal-title":"Gastroenterology."},{"key":"1563_CR73","doi-asserted-by":"publisher","unstructured":"Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J.\u00a0Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease. J Crohns Colitis. 2010;4:603\u20135. https:\/\/doi.org\/10.1016\/j.crohns.2010.05.001.","DOI":"10.1016\/j.crohns.2010.05.001"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-024-01563-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:03:38Z","timestamp":1774364618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-024-01563-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1007\/s12664-024-01563-9","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"27 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eleanor Liu has received a non-pharmaceutical investigator-initiated sponsored research grant from Galapagos, speaker fees from Janssen and consultancy fees from AbbVie.Kelly Chatten has received a non-pharmaceutical investigator-initiated sponsored research grant from Galapagos and speaker fees from Janssen and AbbVie. Jimmy K. Limdi has received consultancy and speaker fees from AbbVie, Arena, Bristol Myers Squibb, Biohit, Celltrion, Eli Lilly, Ferring, Galapagos, Janssen, MSD, Pfizer, Takeda and Tillotts and research grants from AbbVie, Galapagos and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participat"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"All named authors meet the International Committee of Medical Journal Editors (ICJME) criteria for authorship for this article, take responsibility for the integrity of the work and have given their approval for this version to be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}